Consideraciones Farmacológicas para el manejo de SARS-CoV-2 (COVID-19). Primera versión

Código QR

Consideraciones Farmacológicas para el manejo de SARS-CoV-2 (COVID-19). Primera versión

Guardado en:

Detalles Bibliográficos
Autores principales:	Rosales C.,Ruth, González M.,Claudio, Bernal O.,Fernando
Lenguaje:	Spanish / Castilian
Publicado:	Sociedad Chilena de Enfermedades Respiratorias 2020
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-73482020000200138
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Recomendaciones para el diagnóstico y manejo farmacológico en pacientes pediátricos con infección por SARS-CoV-2 (COVID-19)
por: Pavez Azurmendi,Daniela, et al.
Publicado: (2020)

Sars-CoV-2/Covid-19 em Pacientes com Câncer
por: Luiz Claudio Santos Thuler, et al.
Publicado: (2020)

Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19
por: Kening Li, et al.
Publicado: (2020)

Recomendaciones para el estudio y manejo farmacológico en pacientes adultos con sospecha de infección por SARS-CoV-2 (COVID-19)
por: Pérez Godoy,Jorge, et al.
Publicado: (2020)

SARS-CoV-2 immunity and an overview of the COVID-19 vaccines
por: Marković Miloš
Publicado: (2021)

COVID19 – Breve revisión del SARS-CoV-2
por: Anthony Leon
Publicado: (2020)

Consideraciones para la Atención de Urgencia Odontológica y Medidas Preventivas para COVID-19 (SARS-CoV 2)
por: Araya-Salas,Cristóbal
Publicado: (2020)

Consideraciones en la Atención Odontológica de Urgencia en Contexto de Coronavirus COVID-19 (SARS-CoV-2)
por: Sepúlveda-Verdugo,Cristóbal, et al.
Publicado: (2020)

Alteration of Liver Biomarkers in Patients with SARS-CoV-2 (COVID-19)
por: Gholizadeh P, et al.
Publicado: (2020)

Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections
por: Liu T, et al.
Publicado: (2021)

Coronavirus (SARS-CoV-2): Preventions, keys to diagnosis and treatment of SARS-CoV-2
por: Kuldeep Singh Patel, et al.
Publicado: (2020)

Cross-Reactive Antibodies to SARS-CoV-2 and MERS-CoV in Pre-COVID-19 Blood Samples from Sierra Leoneans
por: Rodrigo Borrega, et al.
Publicado: (2021)

Alterations in the Plasma Proteome Induced by SARS-CoV-2 and MERS-CoV Reveal Biomarkers for Disease Outcomes for COVID-19 Patients
por: Alaiya A, et al.
Publicado: (2021)

Testing for SARS-CoV-2
por: Popadić Dušan
Publicado: (2021)

SARS-CoV-2 in cardiomyocytes
por: Josef Finsterer
Publicado: (2021)

Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19
por: Adam K. Wheatley, et al.
Publicado: (2021)

Urinary SARS-CoV-2 RNA Is an Indicator for the Progression and Prognosis of COVID-19
por: Lu Zhang, et al.
Publicado: (2021)

Global dynamics of SARS-CoV-2 clades and their relation to COVID-19 epidemiology
por: Samira M. Hamed, et al.
Publicado: (2021)

Hospitalization and mortality associated with SARS-CoV-2 viral clades in COVID-19
por: Kenji Nakamichi, et al.
Publicado: (2021)

Host transcriptional response to SARS‐CoV‐2 infection in COVID‐19 patients
por: Nitesh Kumar Singh, et al.
Publicado: (2021)

Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge.
por: Antonio Muruato, et al.
Publicado: (2021)

Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge
por: Antonio Muruato, et al.
Publicado: (2021)

Co-Occurrence of SARS-CoV-2 Infection and Inactivated SARS-CoV-2 Vaccination among Healthcare Workers
por: Cucunawangsih Cucunawangsih, et al.
Publicado: (2021)

SARS-CoV-2–Specific Antibodies in Domestic Cats during First COVID-19 Wave, Europe
por: Claudia Schulz, et al.
Publicado: (2021)

SARS CoV-2 seroprevalence in a US school district during COVID-19
por: Benjamin Lee, et al.
Publicado: (2021)

Immune responses to SARS-CoV-2 in three children of parents with symptomatic COVID-19
por: Shidan Tosif, et al.
Publicado: (2020)

One Year of SARS-CoV-2: Genomic Characterization of COVID-19 Outbreak in Qatar
por: Fatiha M. Benslimane, et al.
Publicado: (2021)

Models for COVID-19 Early Cardiac Pathology Following SARS-CoV-2 Infection
por: Maurice Fremont-Smith, et al.
Publicado: (2021)

Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma
por: Kenji Maeda, et al.
Publicado: (2021)

Are smokers protected against SARS-CoV-2 infection (COVID-19)? The origins of the myth
por: Naomi A. van Westen-Lagerweij, et al.
Publicado: (2021)

Clinical and molecular characteristics of COVID-19 patients with persistent SARS-CoV-2 infection
por: Bin Yang, et al.
Publicado: (2021)

Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19
por: Wang-Da Liu, et al.
Publicado: (2021)

Impact of scaling up SARS-CoV-2 vaccination on COVID-19 hospitalizations in Spain
por: Ignacio Barandalla, et al.
Publicado: (2021)

Mechanisms of Immunothrombosis by SARS-CoV-2
por: María Teresa Hernández-Huerta, et al.
Publicado: (2021)

Hotspot Mutations in SARS-CoV-2
por: Indrajit Saha, et al.
Publicado: (2021)

Isothermal amplification and fluorescent detection of SARS-CoV-2 and SARS-CoV-2 variant virus in nasopharyngeal swabs.
por: Les Jones, et al.
Publicado: (2021)

Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunity
por: Hagit Achdout, et al.
Publicado: (2021)

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
por: Xiuyuan Ou, et al.
Publicado: (2020)

SARS-CoV-2 infection in patients with chronic kidney disease on haemodialysis. Evolution of SARS-CoV-2 CRP
por: José Zúñiga, et al.
Publicado: (2021)

Morphometry of SARS-CoV and SARS-CoV-2 particles in ultrathin plastic sections of infected Vero cell cultures
por: Michael Laue, et al.
Publicado: (2021)